Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study

The safety and efficacy of tocilizumab for the treatment of severe respiratory symptoms due to COVID-19 remain uncertain, in particular among solid organ transplant (SOT) recipients. Thus, we evaluated the clinical characteristics and outcomes of 29 hospitalized SOT recipients who received tocilizum...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Transplant
Main Authors: Pereira, Marcus R., Aversa, Meghan M., Farr, Maryjane A., Miko, Benjamin A., Aaron, Justin G., Mohan, Sumit, Cohen, David J., Husain, Syed A., Ratner, Lloyd E., Arcasoy, Selim, Uriel, Nir, Zheng, Elizabeth X., Fox, Alyson N., Tsapepas, Demetra S., Emond, Jean C., Verna, Elizabeth C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Transplantation & American Society of Transplant Surgeons. Published by Elsevier Inc. 2020
Assuntos:
Brief Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7537322/
https://ncbi.nlm.nih.gov/pubmed/32946668
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ajt.16314
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados